Острый коронарный синдром у больных сахарным диабетом 2-го типа
- Авторы: Аметов А.С.1, Пьяных О.П.1, Асландзия Э.Н.1, Ametov AS2, Pianykh OP2, Aslandzia EN2
-
Учреждения:
- ГОУ ДПО РМАПО "Росздрава"
- Выпуск: Том 83, № 9 (2011)
- Страницы: 66-70
- Раздел: Передовая статья
- Статья получена: 10.04.2020
- Статья опубликована: 15.09.2011
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30937
- ID: 30937
Цитировать
Полный текст
Аннотация
Острый интерес к попыткам изменить прогноз ИМ у больных СД с помощью коррекции показателей углеводного обмена лег в основу нескольких многоцентровых исследований (DIGAMI1, DIGAMI2), результаты которых приведены в данной статье.
Ключевые слова
Об авторах
Александр Сергеевич Аметов
ГОУ ДПО РМАПО "Росздрава"
Email: alexander.ametov@gmail.com
Кафедра эндокринологии и диабетологии с курсом эндокринной хирургии- д-р мед. наук, проф., зав. каф. эндокринологии и диабетологии с курсом эндокринной хирургии ГОУ ДПО РМАПО Росздрава, тел.: -495-490-01-14; ГОУ ДПО РМАПО "Росздрава"
Ольга Павловна Пьяных
ГОУ ДПО РМАПО "Росздрава"
Email: docror-olga.p@mail.ru
Кафедра эндокринологии и диабетологии с курсом эндокринной хирургии- аспирант каф. эндокринологии и диабетологии с курсом эндокринной хирургии ГОУ ДПО РМАПО Росздрава, тел.: 8-495-490-02-53; ГОУ ДПО РМАПО "Росздрава"
Эсма Нодаровна Асландзия
ГОУ ДПО РМАПО "Росздрава"
Email: esmin2007@yandex.ru
Кафедра эндокринологии и диабетологии с курсом эндокринной хирургииаспирант тел.: 8-495-490-02-53; ГОУ ДПО РМАПО "Росздрава"
A S Ametov
O P Pianykh
E N Aslandzia
Список литературы
- Juutilainen A. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004; 27: 2898-2904.
- The Task Force on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur. Heart J. 2007; 28: 88-136.
- UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br. Med. J. 1998; 317: 703-713.
- Adler A., Stratton I. M., Neil H. et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Br. Med. J. 2000; 321: 412-419.
- The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension. J. Hypertens. 2007; 25: 1105-1187.
- Stratton I. M., Adler A. I., Neil H. A. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br. Med. J. 2000; 321: 405-412.
- Marso S. P., Lincoff M., Ellis S. G. et al. Optimizing the percutaneous outcome for patients with diabetes mellitus. Results of the EPISCENT Diabetic Substudy. Circulation 1999; 100: 2477-2484.
- Marks J. B., Raskin P. Cardiovascular risk in diabetes. J. Diabet. Complicat. 2000; 14: 108-115.
- Norhammar A., Malmberg K., Ryden L. et al. Under-utilisation of evidence-based treatment partial explanation for the unfavorable prognosis in diabetic patients with acute myocardial infarction. Eur. Heart J. 2003; 24: 838-844.
- Дедов И. И., Александров А. А. Сердечно-сосудистая патология м сахарный диабет. Статины и "микрососудистая ишемия" миокарда. Consilium Medicum. 2004; 9: 4-9.
- Дедов И. И., Бондаренко И. З., Ахматова Ф. Д., Александров А. А. Кардиальная автономная нейропатия в диагностике ишемической болезни сердца у больных сахарным диабетом 1-го типа. Сахар. диабет. 2003; 4: 2-9.
- Otter W., Kleybrink S., Doerig W. et al. Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus. Diabetes Med. 2004; 21: 183-187.
- De Groot M., Auslander W., Williams J. H. et al. Depression and poverty among african american women at risk for type 2 diabetes. Ann. Behav. Med. 2003; 25(3): 172-181.
- Malmberg K., Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur. Heart J. 1988; 9: 256-264.
- Gustafsson I., Hildebrandt P., Seibaek M. et al. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE. Study Group. Eur. Heart J. 2000; 21: 1937-1943.
- Angular D., Solomon S., Kober L. et al. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute miocardial infarction, the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Circulation 2004; 21: 1572- 1578.
- Goyal A., Mahaffey K., Gard J. et al. Prognostic significance of the change in glucose level in the first 24h after acute myocardial infarction, results from the CARDINAL study. Eur. Heart J. 2006; 27: 1289-1297.
- Bartnik M., Ryden L., Ferrari R. et al. Euro Heart Survei Investigators. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. Eur. Heart J. 2004; 25: 1880-1890.
- Malmberg K., Norhammar A., Ryden L. et al. Glucometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study. Circulation 1999; 99: 2626-2632.
- Van den Berghe G., Wouters P. J., Weekers F. et al. Intensive insulin therapy in critically ill patients. N. Engl. J. Med. 2001; 345: 1359-1367.
- Malmberg K., Ryden L., Efendic S. et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J. Am. Coll. Cardiol. 1995; 26: 57-65.
- Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Br. Med. J. 1997; 314: 1512-1515.
- Myocardial infarction redefined-A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur. Heart J. 2000; 21: 1502-1516.
- De Backer G., Ambrosioni E., Borch-Johnsen K. et al. European Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2003; 24: 1601-1610.
- Liebl A., Mata M., Eschwege E. Evaluation of risk factors for development of complications in type 2 diabetes in Europe. Diabetologia 2002; 45: S23-S28.
- Brown J. B., Nichols G. A. Slow response to loss of glycemic control in type 2 diabetes mellitus. Am. J. Manag. Care 2003; 9: 213-217.
- Gudbjernsdottir S., Cederholm J., Nilsson P. M. et al. The National Diabetes Register in Sweden: an implementation of the St Vincent declaration for quality improvements in diabetes care. Diabetes Care 2003; 26: 1270-1276.
- Malmberg K., Ryden L., Wedel H. et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI2): effects on mortality and morbidity. Eur. Heart J. 2005; 26: 650-661.
- Van den Berghe G., Wouters P. J., Bouillon R. et al. Outcome benefit of insulin therapy in the critical ill: insulin dose versus glycemic control. Crit. Care Med. 2003; 31: 359-366.
- Gitt A., Schiele R., Wienbergen H. et al. MITRA study. Intensive treatment of coronary artery disease in diabetic patients in clinical pactice: results of the MITRA study. Acta Diabetol. 2003; 40: S343-S347.
- Schnell O., Doering W., Schefer O. et al. Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction. The Munich registry. Diabetes Care 2004; 27: 455-460.
Дополнительные файлы
![](/img/style/loading.gif)